These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24357812)

  • 1. Circulating T follicular helper cell and regulatory T cell frequencies are influenced by B cell depletion in patients with granulomatosis with polyangiitis.
    Zhao Y; Lutalo PM; Thomas JE; Sangle S; Choong LM; Tyler JR; Tree T; Spencer J; D'Cruz DP
    Rheumatology (Oxford); 2014 Apr; 53(4):621-30. PubMed ID: 24357812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA).
    Henderson SR; Copley SJ; Pusey CD; Ind PW; Salama AD
    Medicine (Baltimore); 2014 Dec; 93(27):e229. PubMed ID: 25501085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.
    Rani L; Minz RW; Sharma A; Anand S; Gupta D; Panda NK; Sakhuja VK
    Cytokine; 2015 Feb; 71(2):261-7. PubMed ID: 25461407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor co-expression reveals aberrantly distributed T
    Lintermans LL; Rutgers A; Stegeman CA; Heeringa P; Abdulahad WH
    Arthritis Res Ther; 2017 Jun; 19(1):136. PubMed ID: 28615072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered follicular regulatory T (Tfr)- and helper T (Tfh)-cell subsets are associated with autoantibody levels in microscopic polyangiitis patients.
    Long Y; Feng J; Ma Y; Sun Y; Xu L; Song Y; Liu C
    Eur J Immunol; 2021 Jul; 51(7):1809-1823. PubMed ID: 33764509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS
    PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
    Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term B-lymphocyte depletion and remission of granulomatosis with polyangiitis after two courses of rituximab treatment.
    Valor-Méndez L; Kleyer A; Rech J; Manger B; Schett G
    Rheumatology (Oxford); 2021 May; 60(5):e162-e164. PubMed ID: 33232468
    [No Abstract]   [Full Text] [Related]  

  • 10. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy.
    Wilde B; Thewissen M; Damoiseaux J; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
    Arthritis Res Ther; 2012 Oct; 14(5):R227. PubMed ID: 23079279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis.
    Szczeklik W; Jakieła B; Wawrzycka-Adamczyk K; Sanak M; Hubalewska-Mazgaj M; Padjas A; Surmiak M; Szczeklik K; Sznajd J; Musiał J
    Eur J Immunol; 2017 Apr; 47(4):724-733. PubMed ID: 28155222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis.
    London J; Dumoitier N; Lofek S; Dion J; Chaigne B; Mocek J; Thieblemont N; Cohen P; Le Jeunne C; Guillevin L; Witko-Sarsat V; Varin-Blank N; Terrier B; Mouthon L;
    Rheumatology (Oxford); 2021 May; 60(5):2157-2168. PubMed ID: 33026090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the identity of FoxP3+ regulatory T cells in Granulomatosis with Polyangiitis patients.
    Reijnders TDY; Stegeman CA; Huitema MG; Rutgers A; Heeringa P; Abdulahad WH
    Sci Rep; 2019 Jun; 9(1):8273. PubMed ID: 31164680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa.
    Shimojima Y; Ishii W; Kishida D; Fukushima K; Ikeda SI
    Mod Rheumatol; 2017 Jan; 27(1):102-109. PubMed ID: 27142840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients.
    Nguyen XH; Dauvilliers Y; Quériault C; Perals C; Romieu-Mourez R; Paulet PE; Bernard-Valnet R; Fazilleau N; Liblau R
    J Autoimmun; 2018 Nov; 94():134-142. PubMed ID: 30104107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
    Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
    J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.
    Stasi R; Cooper N; Del Poeta G; Stipa E; Laura Evangelista M; Abruzzese E; Amadori S
    Blood; 2008 Aug; 112(4):1147-50. PubMed ID: 18375792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease.
    Chen Y; Lin W; Yang H; Wang M; Zhang P; Feng R; Chen H; Peng L; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W; Lipsky PE
    Arthritis Rheumatol; 2018 Nov; 70(11):1853-1865. PubMed ID: 29781221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis.
    Dekkema GJ; Bijma T; Jellema PG; Van Den Berg A; Kroesen BJ; Stegeman CA; Heeringa P; Abdulahad WH; Sanders JS
    Front Immunol; 2019; 10():2170. PubMed ID: 31572380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.